Work package 1 (WP1) aims to ensure good organisation, quality and the achievement of goals for the project. 

In Workpackage 2 (WP2) we follow stroke survivors over a period of 3 years aiming to identify the characteristics of people at risk of function loss. The question we pose are: What are the different trajectories for stroke survivors regarding their function ? What are the different trajectories for stroke survivors regarding their cognitive function? What modifiable and non-modifiable factors are associated with the different trajectories? WP2 is led by professor Bent Indredavik.

Work package 3 (WP3) intends to investigate effectiveness and feasibility implementing patient pathways for stroke survivors after discharge from hospital and up to 3 months after the stroke. We want to find out whether the introduction of patient pathways leads to better function in the stroke survivors. We are further interested in investigating whether the implementation of the patient pathways leads to increased patient satisfaction and if there is a  link between patient pathway adherence and self-perceived health. WP3 is led by department's senior physician Bente Thommessen at Akershus University hospital.

Work package 4 (WP4) intends to evaluate the effect of an individually and multifactorial long-term follow-up by a health coordinator with focus on different domains. Those are physical activity and exercise, cognitive and social stimulation, optimal secondary prevention and other lifestyle factors. In order to prevent functional impairment, we want to answer: Will long-term and regular follow-up by a health coordinator prevent loss of function after a stroke? Will long-term and regular follow-up by a health coordinator prevent new strokes? Does long-term and regular follow-up by a health coordinator lead to better self-perceived health? WP4 is led by Professor Torunn Askim

Work package 5 (WP5) intends to investigate which costs are linked to the patient processes described in WP2. Additionally, we aim to investigate whether the introduction of the new treatment options tested in WP3 and WP4 are cost-effective. The questions we pose are: How do costs change in the years after a stroke? What factors are associated with increased costs? Is the introduction of patient pathways associated with reduced costs and better function compared to previous practice? Is a multimodal intervention cost-effective? WP5 is led by health economist Øystein Døhl, Ph.D.

Work package 6 (WP6) deals with the publication of the results from LAST-long. Our primary goal is to develope a publication and implementation strategy to spread knowledge about the project to researchers, politicians, the general population and people with stroke in particular. WP6 is led by Professor Ingvild Saltvedt